Literature DB >> 34396398

A Review of the Challenges and Complexities in the Diagnosis, Etiology, Epidemiology, and Pathogenesis of Pelvic Inflammatory Disease.

Sharon L Hillier1, Kyle T Bernstein2, Sevgi Aral2.   

Abstract

Pelvic inflammatory disease (PID) is a syndrome that causes substantial morbidity, including chronic pelvic pain, to women globally. While limited data are available from low- and middle-income countries, national databases from the United States and Europe suggest that PID incidence may be decreasing but the rate of decrease may differ by the etiologic cause. Recent studies of women with PID have reported that fewer than half of women receiving a diagnosis of PID have gonococcal or chlamydial infection, while Mycoplasma genitalium, respiratory pathogens, and the constellation of bacteria associated with bacterial vaginosis may account for a substantial fraction of PID cases. The clinical diagnosis of PID is nonspecific, creating an urgent need to develop noninvasive tests to diagnose PID. Advances in serologic testing for Chlamydia trachomatis and Neisseria gonorrhoeae could advance epidemiologic studies, while the development of vaccines against these sexually transmitted pathogens could affect incident PID and associated morbidity.
© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Chlamydia; Mycoplasma genitalium; PID; bacterial vaginosis; endometritis; gonorrhea

Mesh:

Year:  2021        PMID: 34396398      PMCID: PMC8365114          DOI: 10.1093/infdis/jiab116

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   7.759


  29 in total

1.  Sexually transmitted diseases treatment guidelines, 2015.

Authors:  Kimberly A Workowski; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2015-06-05

2.  Vulvovaginitis: causes and management.

Authors:  A M Pierce; C A Hart
Journal:  Arch Dis Child       Date:  1992-04       Impact factor: 3.791

3.  A cluster analysis of bacterial vaginosis-associated microflora and pelvic inflammatory disease.

Authors:  Roberta B Ness; Kevin E Kip; Sharon L Hillier; David E Soper; Carol A Stamm; Richard L Sweet; Peter Rice; Holly E Richter
Journal:  Am J Epidemiol       Date:  2005-08-10       Impact factor: 4.897

4.  Discovery of Blood Transcriptional Endotypes in Women with Pelvic Inflammatory Disease.

Authors:  Xiaojing Zheng; Catherine M O'Connell; Wujuan Zhong; Uma M Nagarajan; Manoj Tripathy; De'Ashia Lee; Ali N Russell; Harold Wiesenfeld; Sharon Hillier; Toni Darville
Journal:  J Immunol       Date:  2018-03-12       Impact factor: 5.422

5.  A Randomized Controlled Trial of Ceftriaxone and Doxycycline, With or Without Metronidazole, for the Treatment of Acute Pelvic Inflammatory Disease.

Authors:  Harold C Wiesenfeld; Leslie A Meyn; Toni Darville; Ingrid S Macio; Sharon L Hillier
Journal:  Clin Infect Dis       Date:  2021-04-08       Impact factor: 9.079

6.  Bacterial vaginosis and anaerobic bacteria are associated with endometritis.

Authors:  Catherine L Haggerty; Sharon L Hillier; Debra C Bass; Roberta B Ness
Journal:  Clin Infect Dis       Date:  2004-09-02       Impact factor: 9.079

7.  Epidemiologic evidence for the development of serovar-specific immunity after gonococcal infection.

Authors:  F A Plummer; J N Simonsen; H Chubb; L Slaney; J Kimata; M Bosire; J O Ndinya-Achola; E N Ngugi
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

8.  Gonococcal salpingitis is less likely to recur with Neisseria gonorrhoeae of the same principal outer membrane protein antigenic type.

Authors:  T M Buchanan; D A Eschenbach; J S Knapp; K K Holmes
Journal:  Am J Obstet Gynecol       Date:  1980-12-01       Impact factor: 8.661

9.  Prevalence of Pelvic Inflammatory Disease in Sexually Experienced Women of Reproductive Age - United States, 2013-2014.

Authors:  Kristen Kreisel; Elizabeth Torrone; Kyle Bernstein; Jaeyoung Hong; Rachel Gorwitz
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-01-27       Impact factor: 17.586

10.  Suppression of host adaptive immune responses by Neisseria gonorrhoeae: role of interleukin 10 and type 1 regulatory T cells.

Authors:  Y Liu; W Liu; M W Russell
Journal:  Mucosal Immunol       Date:  2013-06-12       Impact factor: 7.313

View more
  3 in total

1.  Screening for Chlamydia and Gonorrhea.

Authors:  Jeanne Marrazzo; Jodie Dionne-Odom
Journal:  JAMA       Date:  2021-09-14       Impact factor: 157.335

2.  Public health impact and cost-effectiveness of gonorrhoea vaccination: an integrated transmission-dynamic health-economic modelling analysis.

Authors:  Lilith K Whittles; Xavier Didelot; Peter J White
Journal:  Lancet Infect Dis       Date:  2022-04-12       Impact factor: 71.421

3.  Chlamydia infection, PID, and infertility: further evidence from a case-control study in China.

Authors:  Lijun Liu; Changchang Li; Xuewan Sun; Jie Liu; Hepeng Zheng; Bin Yang; Weiming Tang; Cheng Wang
Journal:  BMC Womens Health       Date:  2022-07-15       Impact factor: 2.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.